Bioverativ
Waltham
About Bioverativ
Bioverativ is a global biotechnology company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Ticker: nasdaq:BIVV
- Website: bioverativ.com
- Phone: +1 781 663 4400
Social Profiles
Canonical: https://fsome.com/organization/bioverativ-2016548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.